Last reviewed: June 24, 2026
Last updated: June 24, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide reaches peak blood levels approximately 1–3 days after injection and maintains therapeutic concentrations for about seven days, making weekly dosing the evidence-based standard. Many people starting their weight loss journey wonder if stretching doses to every 10 days could work as well or cost less—but the clinical data tells a different story.
How Semaglutide Dosing Works in Your Body
Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone controlling hunger and blood sugar. The medication has a half-life of approximately seven days, meaning half of each dose is metabolized and cleared from your system each week. Weekly injections maintain steady-state drug levels needed to suppress appetite, slow gastric emptying, and support sustained weight loss.
Your dose may need to go up over time as your body adapts, but PlexusDx keeps your price flat—starting at $149 per month for compounded semaglutide injection regardless of your current dose level. The standard titration protocol begins at 0.25 mg weekly and increases every four weeks until reaching your therapeutic target, usually between 1.0 and 2.4 mg per week.
Can You Take Semaglutide Every 10 Days Instead of Weekly?
Stretching semaglutide injections to every 10 days creates gaps in therapeutic coverage that undermine weight loss effectiveness. After day seven, plasma concentrations drop significantly, falling below the threshold needed for optimal appetite suppression. Clinical trials establishing semaglutide's safety and efficacy—including the STEP 1, STEP 2, and STEP 3 trials—all used strict weekly dosing schedules, and no peer-reviewed research supports every-10-day injection intervals.
Skipping or delaying doses increases the risk of regaining weight, experiencing hunger spikes between injections, and losing the metabolic benefits that make the medication effective. Some patients attempt off-label dosing to reduce cost, but this strategy typically backfires, requiring higher eventual doses to re-establish results and ultimately costing more over time.
Understanding Dose Escalation and Consistent Pricing
Semaglutide treatment follows a step-wise titration to minimize side effects and maximize tolerance. You start at the lowest dose and move up incrementally every 28 days: 0.25 mg → 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg. This gradual approach helps your body adapt and lets you find your optimal maintenance dose—often somewhere between 1.0 and 2.4 mg weekly.
PlexusDx compounded semaglutide injection begins at $149 per month and remains flat throughout your treatment journey, even as your dose increases. This flat-rate model removes cost barriers to reaching your therapeutic dose and eliminates the anxiety of escalating expenses. All medications come from licensed 503A compounding pharmacies, HSA/FSA eligible, and work in all 50 states without requiring insurance or membership fees.
Personalization: When Your Genetic Profile Matters
While weekly dosing is universal, the *optimal dose* for you may depend on genetic factors affecting how your body processes GLP-1 medications. PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month), which analyzes key variants in genes like GLP1R (rs6923761), GIPR (rs1800437), and others controlling peptide sensitivity and metabolic response. Some patients carry genetic predispositions that make them respond better at lower or higher doses, or that suggest faster or slower titration.
Understanding your genetic peptide profile helps PlexusDx clinicians personalize your starting dose, escalation timeline, and target maintenance level—maximizing results while minimizing side effects. The test maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights, giving you a precision-medicine approach that one-size-fits-all dosing cannot match.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What happens if I take semaglutide every 10 days instead of every 7 days?
Delaying your injection by three days drops your blood levels below the therapeutic range, reducing appetite suppression and weight loss effectiveness. The STEP trials used strict weekly dosing, and changing the schedule without medical supervision can lead to rebound hunger, lost progress, and the need for higher eventual doses. PlexusDx recommends sticking to your prescribed weekly schedule for best results.
How does semaglutide stay in your system?
Semaglutide has a seven-day half-life, meaning 50% of each dose is cleared weekly. Weekly injections maintain steady-state blood levels required for sustained appetite control and metabolic effects. After 10 days between doses, levels drop significantly, breaking the therapeutic window and reducing medication impact.
Does PlexusDx charge more if my semaglutide dose increases?
No. PlexusDx compounded semaglutide injection starts at $149 per month and remains flat regardless of your dose level—whether you're at 0.25 mg or 2.4 mg weekly. Your dose may go up; your price won't. All medications are from licensed 503A compounding pharmacies, HSA/FSA eligible, available in all 50 states without insurance.
Are compounded semaglutide and brand-name Wegovy the same?
Compounded semaglutide contains the same active ingredient and works identically to Wegovy, but comes from licensed 503A compounding pharmacies rather than a pharmaceutical manufacturer. Compounded versions cost significantly less ($149/month vs. $900–$1,500 for brand Wegovy), require no insurance, and offer the same clinical efficacy when dosed weekly as prescribed.
Can the Precision Peptide Genetic Test tell me if I need a different dosing schedule?
The Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, MC4R, and 10 other pathways to predict your individual sensitivity to GLP-1 therapy. While dosing remains weekly, your genetic profile may reveal whether you'll respond optimally at a lower maintenance dose, require faster titration, or might benefit from combination therapy. This personalization helps PlexusDx clinicians tailor your protocol for maximum results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Your Weight Loss Journey: Can You Take Wegovy and Orlistat Together?
When Does Wegovy Start Suppressing Appetite?